Authors:
CULLEN JM
SMITH SL
DAVIS MG
DUNN SE
BOTTERON C
CECCHI A
LINSEY D
LINZEY D
FRICK L
PAFF MT
GOULDING A
BIRON K
Citation: Jm. Cullen et al., IN-VIVO ANTIVIRAL ACTIVITY AND PHARMACOKINETICS OF -1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE IN WOODCHUCK HEPATITIS VIRUS-INFECTEDWOODCHUCKS, Antimicrobial agents and chemotherapy, 41(10), 1997, pp. 2076-2082
Citation: Ld. Condreay et al., -1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE (524W91) INHIBITS HEPATITIS-B VIRUS-REPLICATION IN PRIMARY HUMAN HEPATOCYTES, Antimicrobial agents and chemotherapy, 40(2), 1996, pp. 520-523
Authors:
NAIR V
STCLAIR MH
REARDON JE
KRASNY HC
HAZEN RJ
PAFF MT
BOONE LR
TISDALE M
NAJERA I
DORNSIFE RE
AVERETT DR
BORROTOESODA K
YALE JL
ZIMMERMAN TP
RIDEOUT JL
Citation: V. Nair et al., ANTIVIRAL, METABOLIC, AND PHARMACOKINETIC PROPERTIES OF THE ISOMERIC DIDEOXYNUCLEOSIDE -AMINO-9H-PURIN-9-YL)TETRAHYDRO-2(S)-FURANMETHANOL, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 1993-1999
Authors:
PAFF MT
AVERETT DR
PRUS KL
MILLER WH
NELSON DJ
Citation: Mt. Paff et al., INTRACELLULAR METABOLISM OF (-) AND -1-[2(HHYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE IN HEPG2 DERIVATIVE 2.2.15 (SUBCLONE P5A) CELLS()), Antimicrobial agents and chemotherapy, 38(6), 1994, pp. 1230-1238
Authors:
CONDREAY LD
JANSEN RW
POWDRILL TF
JOHNSON LC
SELLESETH DW
PAFF MT
DALUGE SM
PAINTER GR
FURMAN PA
ELLIS MN
AVERETT DR
Citation: Ld. Condreay et al., EVALUATION OF THE POTENT ANTI-HEPATITIS-B VIRUS AGENT -1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE IN A NOVEL IN-VIVO MODEL, Antimicrobial agents and chemotherapy, 38(3), 1994, pp. 616-619